Vertex Pharmaceuticals Incorporated (VRTX) |
|
229.06 -4.85 (-2.07%)
|
01-24 16:00 |
|
Open: |
234.07 |
Pre. Close: |
233.91 |
|
High:
|
235.18 |
Low:
|
228.415 |
|
Volume:
|
904,271 |
Market Cap:
|
58903M |
|
|
|
|
Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
235.462 - 236.934 |
236.934 - 237.972 |
|
Low:
|
224.931 - 226.761 |
226.761 - 228.051 |
|
Close:
|
226.671 - 229.335 |
229.335 - 231.213 |
|
Technical analysis |
as of: 2020-01-24 4:36:41 PM |
|
Overall:
|
 |
| Stoxline posted a STRONG SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 277.36 One year: 323.96 |
| Support: |
Support1: 223.31 Support2: 214.55 |
| Resistance: |
Resistance1: 237.47 Resistance2: 277.36 |
| Pivot: |
229.96  |
| Moving Average: |
MA(5): 233.48  MA(20): 227.40
MA(100): 201.12 MA(250): 187.69 |
| MACD: |
MACD(12,26): 4.13 Signal(9): 4.21 |
| Stochastic oscillator: |
%K(14,3): 78.43 %D(3): 84.82 |
| RSI: |
RSI(14): 54.96 |
| 52-week: |
High: 237.47 Low: 163.68 Change(%): 21.8 |
| Average Vol(K): |
3-Month: 132369 10-Days: 128299 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.VRTX has closed above bottom band by 45.5%. Bollinger Bands are 15.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2020-01-23
Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: Should You Buy?
Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2020-01-23
The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 22) 10X Genomics Inc (NASDAQ: TXG ) Abbott Laboratories (NYSE: ABT )(reported strong fourth-quarter results and issued in-line guidance) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) AtriCure Inc. (NASDAQ: ATRC ) BIO-TECHNE Corp (NASDAQ: TECH ) Bristol-Myers Squibb Co (NYSE: BMY ) Cardiovascular Systems Inc (NASDAQ: CSII ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Eli Lilly And Co (NYSE: LLY ) Fortress Biotech (NASDAQ: FBIO ) Horizon Therapeutics PLC (NASDAQ: HZNP )( received FDA nod for its thyroid eye disease drug) Insulet Corporation (NASDAQ: PODD ) Medtronic PLC (NYSE: MDT ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Nevro Corp (NYSE: NVRO ) Novocure Ltd (NASDAQ: NVCR )(announced coverage in Israel for its Optune in combination with temozolomide for the treatment of newly-diagnosed glioblastoma) Prevail Therapeutics Inc (NASDAQ: PRVL ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Selecta Biosciences Inc (NASDAQ: SELB ) SI-Bone Inc (NASDAQ: SIBN ) Soligenix, Inc.
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
